NSCLC	Non-small cell lung cancer
EGFR	Epidermal growth factor receptor
TKI	Tyrosine kinase inhibitor
ALK	Anaplastic lymphoma kinase
PD-1	Programmed death 1
PD-L1	Programmed death-ligand 1
FDA	Food and Drug Administration
PFS	Progression-free survival
OS	Overall survival
DFS	Disease-free survival
MPR	Major pathologic response
ECOG	Eastern Cooperative Oncology Group
PCR	Polymerase chain reaction
NGS	Next generation sequencing
FISH	Fluorescence in situ hybridization
ctDNA	Circulating tumor DNA
CI	Confidence interval
EFS	Event-free survival
CNS	Central nervous system